Diseases of the respiratory system cardiovascular System
Diseases of the respiratory system cardiovascular System
My sudden blood pressure diagnosis came at a time when I was too stressed. I was getting frequent headaches but always associated with long hours in front of the screen. Dr. told me to control my blood pressure with medicines, lifestyle changes and diet, or I could get a stroke. My husband bought me Cardio Balance to help me lower down my bp naturally. He was the one who monitored my reading. And to our amazement, it reduced from around 145/115 to 124/82 and stayed there. Honestly, it’s a lifesaver for me.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
Respiratory and heart in line for your well-being Discomfort in breathing or circulation? You are not alone: diseases of the respiratory system and the cardiovascular system are among the most common health problems of our time. What can you do to help? Our medical Team is at your side — from early prevention to targeted treatment. We offer: comprehensive screening for lung and heart; modern diagnostics for the early detection of risk factors; individual counseling for chronic diseases (such as COPD, Asthma, congestive heart failure or high blood pressure); tailor-made programs to strengthen the breathing and heart health; Training for the lifestyle optimization: Smoking cessation, healthy diet, measured movement. Why act now? Early detection saves lives. A simple investigation can prevent today, long-term complications and quality of life increased significantly. Appointment — your way to more energy of life Call us or write an E‑Mail. We advise you to bring trustworthy, competent, and with the goal of getting your heart and your breathing back into Balance. Health begins with a single step. You can make it today.
Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. Diseases of the respiratory system cardiovascular System. Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.
Epidemiology and prevention of cardiovascular diseases
Diseases of the circulatory System-treatment medications
A violation of the cardiovascular System disease
http://orunikat.beget.tech/articles/49315-15-prevention-of-cardiovascular-diseases.html
Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
Stratification of the risk of cardiovascular disease: foundations and clinical application The stratification of the risk of cardiovascular disease (CVD) constitutes a Central Element of modern preventive medicine. Your goal is the identification of individuals with increased risk for cardiovascular events such as myocardial infarction, stroke, or sudden cardiac death is to preventive measures aimed to initiate. Fundamentals of risk stratification The risk assessment is based on the Integration of multiple factors, which can be divided into two main groups: Modifiable Risk Factors: Hypertension (blood pressure≥140/90 mmHg); Dyslipidemia (elevated LDL cholesterol, low HDL‑cholesterol values); Tobacco consumption (active and passive Smoking); Diabetes mellitus (elevated HbA 1c ); Overweight and obesity (BMI ≥25 kg/m 2 ); physical inactivity; unhealthy diet (high in salt, sugar and TRANS fat consumption). Non-modifiable risk factors: Age (men ≥45 years, women ≥55 years of age or after Menopause); Gender (higher risk in men, in younger age groups); family history of early CVD (incidents in first-degree Relatives: men, 55 years for women and 65 years ago). Instruments for risk estimation For the standardized risk assessment, different Scores are used: SCORE System (Systematic COronary Risk Evaluation): The 10‑year calculated risk for a fatal cardiovascular events on the Basis of age, gender, blood pressure, cholesterol and Smoking status. Framingham‑Risk Core: Determines 10‑year risk for coronary heart disease with the involvement of similar parameters. ASCVD risk calculator (Atherosclerotic Cardiovascular Disease): It is used mainly in the United States and taken into account in addition to HDL‑cholesterol. Stages of risk stratification On the basis of the calculated risk patients are divided values into the following categories: Low Risk: <1,0% (SCORE) — Health information and lifestyle advice. Moderate risk: 1,0–4,9% — more and better advice, if necessary, drug Intervention in the case of individual factors (e.g., hypertension). The high-risk range: 5.0–9.9% of the combined preventive strategies, medications for blood pressure and lipid-lowering. Very high risk: ≥10.0% or existing CVD — aggressive risk factor reduction, intensive Monitoring. Current developments and extensions In addition to the conventional Scores of additional markers will be discussed to improve the risk stratification: Coronary calcium Scoring (CAC Score) by means of CT; Measurement of high-sensitive C‑reactive Protein (hs‑CRP); Family history on the second-degree line; genetic-risk profiles. Conclusion The evidence-based stratification of cardiovascular risk allows for a differentiated prevention strategy. Through the identification of high-risk persons, the incidence of coronary heart can be reduced events significantly. The continuous development of risk models, and the Integration of new biomarkers will improve the precision of risk assessment in the future.